Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,901 papers from all fields of science
Search
Sign In
Create Free Account
synerazol
Known as:
1-Oxa-7-azaspiro(4.4)non-2-ene-4,6-dione, 8-benzoyl-2-(3-(1-butenyl)oxiranyl)-9-hydroxy-8-methoxy-3-methyl-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyrrolidinones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Chemical Modification of Pseurotin A: One-pot Synthesis of Synerazol and Pseurotin E and Determination of Absolute Stereochemistry of Pseurotin E
M. Ishikawa
,
T. Ninomiya
Journal of antibiotics (Tokyo. )
2008
Corpus ID: 13478800
Two natural products, synerazol and pseurotin E, were synthesized from the natural product pseurotin A in 58% and 57% yields…
Expand
2006
2006
NEW ANTIFUNGAL ANTIBIOTIC
O. Ando
,
H. Satake
,
+4 authors
Tatsuo Haneishic
2006
Corpus ID: 7747381
In the course of our screening programs for new antifungal antibiotics, a new fungal metabolite, synerazol* was isolated. The…
Expand
2005
2005
First asymmetric total synthesis of synerazol, an antifungal antibiotic, and determination of its absolute stereochemistry.
Y. Hayashi
,
M. Shoji
,
+5 authors
H. Osada
Journal of Organic Chemistry
2005
Corpus ID: 8538191
[reaction: see text] By synthesizing two possible diastereomers, the first asymmetric total synthesis of synerazol, an antifungal…
Expand
2004
2004
Directed biosynthesis of fluorinated pseurotin A, synerazol and gliotoxin.
Y. Igarashi
,
Y. Yabuta
,
+6 authors
T. Oki
Journal of antibiotics (Tokyo. )
2004
Corpus ID: 21981794
Aspergillus fumigatus TP-F0196 produces pseurotin A, synerazol and gliotoxin. Phenylalanine is a common biosynthetic precursor of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE